Scientific session – Multi-cancer early detection: what’s happening and what’s on the horizon

Amphitheatre D (level +1)
Regular session

Information

Session organised by International Agency for Research on Cancer

Chaired by Hilary Robbins, International Agency for Research on Cancer (IARC) (France)

Presentations:

1. The Landscape of Multi-Cancer Early Detection Tests and their Potential Benefits & Harms - Hilary Robbins, International Agency for Research on Cancer (IARC) (France)

2. Update on Multi-Cancer Early Detection in the USA: Plans for Trials and Regulation - Lori Minasian, US National Cancer Institute (United States)

3. Update on Multi-Cancer Early Detection in the United Kingdom: Ongoing Research and Potential Roll-Out - Richard Lee, The Royal Marsden NHS Foundation Trust (United Kingdom)

4. Should Multi-Cancer Early Detection Tests be Considered for Use in LMICs? - Hesham El Ghazaly, Ain Shams University (Egypt)

5. How Should we Evaluate the Utility of Multi-Cancer Early Detection Tests? - Ruth Etzioni, Fred Hutchinson Cancer Center (United States)

Theme
1. Prevention, screening and early detection
Objectives
Rapid technological developments in the last decade have led to the development of blood tests that aim to detect multiple cancer types simultaneously. Efforts to evaluate and implement these tests are particularly active in the United Kingdom and the USA. This session will provide an update on the field of multi-cancer early detection and review the key considerations for policymakers, funders, researchers, clinicians, and guideline-making bodies.Participants will be provided with frameworks and study design considerations for quantifying the benefits and harms of multi-cancer early detection tests.
"Leaders session"
Leaders' Session

Log in

See all the content and easy-to-use features by logging in or registering!